This autocrine loop involving IGF-2 and the isoform IR-A is activated in different cancers and particularly in the PDTC histotypes [16,17,18], and exerts a crucial role in regulating stem-like properties, metastases, and resistance to therapies [19,20,21,22]. This evidence concerns the gene IGF2 and cancer.